Results 191 to 200 of about 7,404,806 (258)

Cardiac Tamponade After Late Central Venous Catheter Dislodgement in Two Pediatric Patients-A Rare but Potentially Fatal Complication. [PDF]

open access: yesChildren (Basel)
Ivanov Z   +8 more
europepmc   +1 more source

Improving venous thromboembolism prophylaxis in hospitalized pediatric patients with inflammatory bowel disease

open access: yesJPGN Reports, EarlyView.
Abstract Objectives Youth hospitalized with inflammatory bowel disease (IBD) are at risk for venous thromboembolism (VTE). Pharmacologic VTE prophylaxis with enoxaparin is routine in adults hospitalized with IBD, but standardized pediatric protocols are rare.
Laura G. Hamant   +5 more
wiley   +1 more source

Barriers to optimal central venous catheter training: a qualitative study of physician experiences. [PDF]

open access: yesBMC Med Educ
Abou Farah J   +10 more
europepmc   +1 more source

New filamin A gene mutation identified in X‐linked pediatric intestinal pseudo‐obstruction: A case report

open access: yesJPGN Reports, EarlyView.
Abstract Pediatric intestinal pseudo‐obstruction (PIPO) represents a severe gut motility disorder leading to digestive complications with high morbidity and mortality. Neonates and young children present symptoms mimicking intestinal occlusion, leading to surgery and long‐term feeding support.
Leonor Belfond   +6 more
wiley   +1 more source

Standardized Reporting of Cardiac Magnetic Resonance Examinations in Children With Cardiac Diseases and Adults With Congenital Heart Disease: A Scientific Statement From the Association for European Pediatric and Congenital Cardiology (AEPC) and the International Society for Magnetic Resonance in Medicine (ISMRM)

open access: yes
Journal of Magnetic Resonance Imaging, EarlyView.
Francesca Raimondi   +26 more
wiley   +1 more source

Diffuse gallbladder epithelial proliferation after teduglutide exposure: A case report

open access: yesJPGN Reports, EarlyView.
Abstract Teduglutide, a glucagon‐like peptide 2 analog that increases mucosal proliferation in the gastrointestinal tract, was approved by the U.S. Food and Drug Administration for use in children with intestinal failure in 2019 after trials of 12‐ and 24‐week duration.
Christopher P. Duggan   +4 more
wiley   +1 more source

Beyond enteral feedings: Teduglutide and its role in gut resiliency

open access: yesJPGN Reports, EarlyView.
Abstract Teduglutide is a glucagon‐like peptide‐2 (GLP‐2) analog that promotes intestinal adaptation with a goal of reducing dependence on parenteral nutrition (PN) in those with short bowel syndrome (SBS). We describe a 2‐year‐old, born at 26 weeks gestation, with a history of PN dependency due to recurrent necrotizing enterocolitis (NEC) and ...
Heather Grabow   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy